Did a targeted drug help leukemia patients stay cancer-free longer after transplant?
Knowledge-focused
Completed
This study looked at people with a specific genetic form of acute myeloid leukemia (FLT3-mutated) whose cancer returned or didn't respond to treatment. Researchers compared those who took the drug gilteritinib after a stem cell transplant to those who received standard care, usin…
Sponsor: Astellas Pharma Singapore Pte. Ltd. • Aim: Knowledge-focused
Last updated May 07, 2026 18:38 UTC